Home › Funds › Atle Fund Management AB › DXCM
Atle Fund Management AB position in DXCM
DEXCOM · Health Care
Atle Fund Management AB reported holding 89,251 shares of DXCM (DEXCOM) in its Q3 2026 13F filing — a position valued at US$7.7M, representing 2.06% of its reported portfolio and ranking #19 among its reported holdings. Atle Fund Management AB has disclosed DXCM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Atle Fund Management AB's DXCM position evolved
Atle Fund Management AB first disclosed a stake in DXCM in Q4 2023 at 18,057 shares (US$2.2M). The position peaked in Q3 2026 at 89,251 shares, worth US$7.7M. Across 12 filings, Atle Fund Management AB increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 89,251 shares valued at US$7.7M — an increase of 17,405 shares quarter over quarter.. Notable position changes include a 56% increase in Q3 2024 (shares rose 17% over the following quarter), a 1371% increase in Q1 2026 (shares rose 7% over the following quarter), a 88% trim in Q2 2026 (shares rose 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 18.06K | $2.24M | New |
| Q1 2024 | 26.28K | $3.65M | Add |
| Q2 2024 | 34.48K | $3.91M | Add |
| Q3 2024 | 53.76K | $3.60M | Add |
| Q4 2024 | 60.06K | $4.68M | Add |
| Q1 2025 | 45.84K | $3.13M | Reduce |
| Q2 2025 | 50.87K | $4.44M | Add |
| Q3 2025 | 50.87K | $363.42K | Hold |
| Q4 2025 | 39.72K | $2.64M | Reduce |
| Q1 2026 | 584.33K | $2.64M | Add |
| Q2 2026 | 71.85K | $4.84M | Reduce |
| Q3 2026 | 89.25K | $7.70M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DXCM and 13F data
DXCM (DEXCOM) is a Health Care company. 27 other funds we track also report a position in DXCM — the largest reported positions include Baillie Gifford & Co (US$996.9M), Castle Hook Partners LP (US$260.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DXCM
- Baillie Gifford & Co 14.80M sh · $996.89M · Q2 2026
- Castle Hook Partners LP 3.87M sh · $260.67M · Q2 2026
More on Atle Fund Management AB
FAQ
How long has Atle Fund Management AB held DXCM?
Atle Fund Management AB has disclosed DXCM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Atle Fund Management AB's current position in DXCM?
As of Q3 2026, Atle Fund Management AB holds 89.25K shares of DXCM (DEXCOM), valued at $7.70M, representing 2.06% of its reported portfolio and ranking #19.
Has Atle Fund Management AB been buying or selling DXCM?
In the latest 13F filing (Q3 2026), Atle Fund Management AB increased its position in DXCM. The position peaked in Q3 2026 at 89.25K shares.
Which other funds hold DXCM?
Other major institutional holders of DXCM include Baillie Gifford & Co, Castle Hook Partners LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.